These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9129026)

  • 1. A soluble tissue factor mutant is a selective anticoagulant and antithrombotic agent.
    Kelley RF; Refino CJ; O'Connell MP; Modi N; Sehl P; Lowe D; Pater C; Bunting S
    Blood; 1997 May; 89(9):3219-27. PubMed ID: 9129026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing the anticoagulant potency of soluble tissue factor mutants by increasing their affinity to factor VIIa.
    Yang J; Lee GF; Riederer MA; Kelley RF
    Thromb Haemost; 2002 Mar; 87(3):450-8. PubMed ID: 11916078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of arterial thrombosis by a soluble tissue factor mutant and active site-blocked factors IXa and Xa in the guinea pig.
    Himber J; Refino CJ; Burcklen L; Roux S; Kirchhofer D
    Thromb Haemost; 2001 Mar; 85(3):475-81. PubMed ID: 11307818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMS-593214, an active site-directed factor VIIa inhibitor: enzyme kinetics, antithrombotic and antihaemostatic studies.
    Wong PC; Luettgen JM; Rendina AR; Kettner CA; Xin B; Knabb RM; Wexler R; Priestley ES
    Thromb Haemost; 2010 Aug; 104(2):261-9. PubMed ID: 20589312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The N-terminal epidermal growth factor-like domain in factor IX and factor X represents an important recognition motif for binding to tissue factor.
    Zhong D; Bajaj MS; Schmidt AE; Bajaj SP
    J Biol Chem; 2002 Feb; 277(5):3622-31. PubMed ID: 11723140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor.
    Arnold CS; Parker C; Upshaw R; Prydz H; Chand P; Kotian P; Bantia S; Babu YS
    Thromb Res; 2006; 117(3):343-9. PubMed ID: 16378835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex.
    Sato Y; Asada Y; Marutsuka K; Hatakeyama K; Kamikubo Y; Sumiyoshi A
    Thromb Haemost; 1997 Sep; 78(3):1138-41. PubMed ID: 9308767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2.
    Bergum PW; Cruikshank A; Maki SL; Kelly CR; Ruf W; Vlasuk GP
    J Biol Chem; 2001 Mar; 276(13):10063-71. PubMed ID: 11139576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey.
    Beeler DL; Aird WC; Grant MA
    J Thromb Haemost; 2018 Apr; 16(4):734-748. PubMed ID: 29418058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa Gla domain is dispensable for binding to tissue factor but important for activation of factor X.
    Neuenschwander PF; Morrissey JH
    J Biol Chem; 1994 Mar; 269(11):8007-13. PubMed ID: 8132522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factor.
    Ferrière S; Kawecki C; Ottavi JF; Denis CV; Kauskot A; Christophe OD; Lenting PJ
    J Thromb Haemost; 2019 Dec; 17(12):2035-2046. PubMed ID: 31423724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biochemical basis for the apparent defect of soluble mutant tissue factor in enhancing the proteolytic activities of factor VIIa.
    Fiore MM; Neuenschwander PF; Morrissey JH
    J Biol Chem; 1994 Jan; 269(1):143-9. PubMed ID: 8276788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease nexin-2/Amyloid beta-protein precursor regulates factor VIIa and the factor VIIa-tissue factor complex.
    Mahdi F; Rehemtulla A; Van Nostrand WE; Bajaj SP; Schmaier AH
    Thromb Res; 2000 Aug; 99(3):267-76. PubMed ID: 10942793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor-1 inhibits factor VIIa bound to tissue factor.
    Sen P; Komissarov AA; Florova G; Idell S; Pendurthi UR; Vijaya Mohan Rao L
    J Thromb Haemost; 2011 Mar; 9(3):531-9. PubMed ID: 21143380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular determinants involved in differential behaviour between soluble tissue factor and full-length tissue factor towards factor VIIa.
    Prasad R; Sen P
    Phys Chem Chem Phys; 2017 Aug; 19(33):22230-22242. PubMed ID: 28799584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beating tissue factor at its own game: Design and properties of a soluble tissue factor-independent coagulation factor VIIa.
    Sorensen AB; Tuneew I; Svensson LA; Persson E; Østergaard H; Overgaard MT; Olsen OH; Gandhi PS
    J Biol Chem; 2020 Jan; 295(2):517-528. PubMed ID: 31801825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitution of aspartic acid for methionine-306 in factor VIIa abolishes the allosteric linkage between the active site and the binding interface with tissue factor.
    Persson E; Nielsen LS; Olsen OH
    Biochemistry; 2001 Mar; 40(11):3251-6. PubMed ID: 11258943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of activated factor VII and active site-inhibited activated factor VII with tissue factor.
    Sørensen BB; Rao LV
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S67-71. PubMed ID: 9819031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the Gla and first epidermal growth factor-like domains of factor X in the prothrombinase and tissue factor-factor VIIa complexes.
    Thiec F; Cherel G; Christophe OD
    J Biol Chem; 2003 Mar; 278(12):10393-9. PubMed ID: 12529356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.